Literature DB >> 24510619

Dextran sulfate sodium (DSS)-induced colitis in mice.

Benoit Chassaing1, Jesse D Aitken1, Madhu Malleshappa1, Matam Vijay-Kumar2,3.   

Abstract

Inflammatory bowel diseases (IBD), mainly comprising ulcerative colitis and Crohn's Disease, are complex and multifactorial diseases with unknown etiology. For the past 20 years, to study human IBD mechanistically, a number of murine models of colitis have been developed. These models are indispensable tools to decipher underlying mechanisms of IBD pathogenesis as well as to evaluate a number of potential therapeutics. Among various chemically induced colitis models, the dextran sulfate sodium (DSS)-induced colitis model is widely used because of its simplicity and many similarities with human ulcerative colitis. This model has both advantages and disadvantages that must be considered when employed. This protocol describes the DSS-induced colitis model, focusing on details and factors that could affect DSS-induced pathology.
Copyright © 2014 John Wiley & Sons, Inc.

Entities:  

Keywords:  chemical colitogen; inflammatory bowel disease; intestinal inflammation; myeloperoxidase; occult blood; ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24510619      PMCID: PMC3980572          DOI: 10.1002/0471142735.im1525s104

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  36 in total

1.  Differential role of tumor necrosis factor receptors in TNBS colitis.

Authors:  Dawn R Ebach; Rodney Newberry; William F Stenson
Journal:  Inflamm Bowel Dis       Date:  2005-06       Impact factor: 5.325

2.  Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme.

Authors:  Elise M J van der Logt; Tjasso Blokzijl; Roelof van der Meer; Klaas Nico Faber; Gerard Dijkstra
Journal:  J Nutr Biochem       Date:  2012-12-12       Impact factor: 6.048

3.  Activation of toll-like receptor 3 protects against DSS-induced acute colitis.

Authors:  Matam Vijay-Kumar; Huixia Wu; Jesse Aitken; Vasantha L Kolachala; Andrew S Neish; Shanthi V Sitaraman; Andrew T Gewirtz
Journal:  Inflamm Bowel Dis       Date:  2007-07       Impact factor: 5.325

4.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

5.  Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis.

Authors:  Lisa S Poritz; Kristian I Garver; Cecelia Green; Leo Fitzpatrick; Francesca Ruggiero; Walter A Koltun
Journal:  J Surg Res       Date:  2007-04-06       Impact factor: 2.192

6.  TLR9 is important for protection against intestinal damage and for intestinal repair.

Authors:  William Alfred Rose; Kaori Sakamoto; Cynthia Anne Leifer
Journal:  Sci Rep       Date:  2012-08-14       Impact factor: 4.379

7.  Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colon.

Authors:  Hamed Laroui; Sarah A Ingersoll; Hong Chun Liu; Mark T Baker; Saravanan Ayyadurai; Moiz A Charania; Famina Laroui; Yutao Yan; Shanthi V Sitaraman; Didier Merlin
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

8.  The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation.

Authors:  Lílian G Teixeira; Alda J Leonel; Edenil C Aguilar; Nathália V Batista; Andréa C Alves; Candido C Coimbra; Adaliene V M Ferreira; Ana Maria C de Faria; Denise C Cara; Jacqueline I Alvarez Leite
Journal:  Lipids Health Dis       Date:  2011-11-10       Impact factor: 3.876

9.  Opposite role of tumor necrosis factor receptors in dextran sulfate sodium-induced colitis in mice.

Authors:  Ke Wang; Gencheng Han; Yan Dou; Yi Wang; Guijun Liu; Renxi Wang; He Xiao; Xinying Li; Chunmei Hou; Beifen Shen; Renfeng Guo; Yan Li; Yanchun Shi; Guojiang Chen
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation.

Authors:  Benoit Chassaing; Gayathri Srinivasan; Maria A Delgado; Andrew N Young; Andrew T Gewirtz; Matam Vijay-Kumar
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more
  427 in total

1.  Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease.

Authors:  Khaled Greish; Safa Taha; Anfal Jasim; Sara Abd Elghany; Ameera Sultan; Ali AlKhateeb; Manal Othman; Fang Jun; Sebastien Taurin; Moiz Bakhiet
Journal:  Clin Transl Med       Date:  2017-08-03

2.  Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Authors:  Sufeng Zhang; Won Joon Cho; Amy T Jin; Lie Yun Kok; Yunhua Shi; David E Heller; Young-Ah Lucy Lee; Yixuan Zhou; Xi Xie; Joshua R Korzenik; Jochen K Lennerz; Giovanni Traverso
Journal:  Adv Healthc Mater       Date:  2020-06-29       Impact factor: 9.933

3.  Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation.

Authors:  Yang Chen; Yan Jin; Catherine Stanton; R Paul Ross; Jianxin Zhao; Hao Zhang; Bo Yang; Wei Chen
Journal:  Eur J Nutr       Date:  2020-04-29       Impact factor: 5.614

4.  Pharmacological inhibition of GPR4 remediates intestinal inflammation in a mouse colitis model.

Authors:  Edward J Sanderlin; Mona Marie; Juraj Velcicky; Pius Loetscher; Li V Yang
Journal:  Eur J Pharmacol       Date:  2019-03-28       Impact factor: 4.432

5.  Lactobacillus fermentum species ameliorate dextran sulfate sodium-induced colitis by regulating the immune response and altering gut microbiota.

Authors:  You Jin Jang; Woon-Ki Kim; Dae Hee Han; Kiuk Lee; Gwangpyo Ko
Journal:  Gut Microbes       Date:  2019-04-03

6.  BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice.

Authors:  Kalung Cheung; Geming Lu; Rajal Sharma; Adam Vincek; Ruihua Zhang; Alexander N Plotnikov; Fan Zhang; Qiang Zhang; Ying Ju; Yuan Hu; Li Zhao; Xinye Han; Jamel Meslamani; Feihong Xu; Anbalagan Jaganathan; Tong Shen; Hongfa Zhu; Elena Rusinova; Lei Zeng; Jiachi Zhou; Jianjun Yang; Liang Peng; Michael Ohlmeyer; Martin J Walsh; David Y Zhang; Huabao Xiong; Ming-Ming Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

7.  Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis.

Authors:  Karl Katholnig; Birgit Schütz; Stephanie D Fritsch; David Schörghofer; Monika Linke; Nyamdelger Sukhbaatar; Julia M Matschinger; Daniela Unterleuthner; Martin Hirtl; Michaela Lang; Merima Herac; Andreas Spittler; Andreas Bergthaler; Gernot Schabbauer; Michael Bergmann; Helmut Dolznig; Markus Hengstschläger; Mark A Magnuson; Mario Mikula; Thomas Weichhart
Journal:  JCI Insight       Date:  2019-10-17

8.  Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis.

Authors:  Hiroki Saijo; Norifumi Tatsumi; Seiji Arihiro; Tomohiro Kato; Masataka Okabe; Hisao Tajiri; Hisashi Hashimoto
Journal:  Lab Invest       Date:  2015-05-04       Impact factor: 5.662

9.  RNA Purity, Real-Time PCR Sensitivity, and Colon Segment Influence mRNA Relative Expression in Murine Dextran Sodium Sulfate Experimental Colitis.

Authors:  Bernardo Oldak; Mayra Cruz-Rivera; Ana Flisser; Fela Mendlovic
Journal:  J Biomol Tech       Date:  2018-07-13

10.  Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.

Authors:  Veronika Butin-Israeli; Triet M Bui; Hannah L Wiesolek; Lorraine Mascarenhas; Joseph J Lee; Lindsey C Mehl; Kaitlyn R Knutson; Stephen A Adam; Robert D Goldman; Arthur Beyder; Lisa Wiesmuller; Stephen B Hanauer; Ronen Sumagin
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.